276 related articles for article (PubMed ID: 33408226)
41. Pivotal role of the C-terminal DW-motif in mediating inhibition of pyruvate dehydrogenase kinase 2 by dichloroacetate.
Li J; Kato M; Chuang DT
J Biol Chem; 2009 Dec; 284(49):34458-67. PubMed ID: 19833728
[TBL] [Abstract][Full Text] [Related]
42. Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate.
Dhar S; Lippard SJ
Proc Natl Acad Sci U S A; 2009 Dec; 106(52):22199-204. PubMed ID: 20007777
[TBL] [Abstract][Full Text] [Related]
43. Effects of dichloroacetate on brain pyruvate dehydrogenase.
Abemayor E; Kovachich GB; Haugaard N
J Neurochem; 1984 Jan; 42(1):38-42. PubMed ID: 6689696
[TBL] [Abstract][Full Text] [Related]
44. Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC.
Stockwin LH; Yu SX; Borgel S; Hancock C; Wolfe TL; Phillips LR; Hollingshead MG; Newton DL
Int J Cancer; 2010 Dec; 127(11):2510-9. PubMed ID: 20533281
[TBL] [Abstract][Full Text] [Related]
45. The Role of Pyruvate Dehydrogenase Kinase-4 (PDK4) in Bladder Cancer and Chemoresistance.
Woolbright BL; Choudhary D; Mikhalyuk A; Trammel C; Shanmugam S; Abbott E; Pilbeam CC; Taylor JA
Mol Cancer Ther; 2018 Sep; 17(9):2004-2012. PubMed ID: 29907593
[TBL] [Abstract][Full Text] [Related]
46. Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target.
Hur H; Xuan Y; Kim YB; Lee G; Shim W; Yun J; Ham IH; Han SU
Int J Oncol; 2013 Jan; 42(1):44-54. PubMed ID: 23135628
[TBL] [Abstract][Full Text] [Related]
47. Detection of pyruvate metabolism disorders by culture of skin fibroblasts with dichloroacetate.
Naito E; Kuroda Y; Takeda E; Yokota I; Kobashi H; Miyao M
Pediatr Res; 1988 Jun; 23(6):561-4. PubMed ID: 2839811
[TBL] [Abstract][Full Text] [Related]
48. Activation of Pyruvate Dehydrogenase by Sodium Dichloroacetate Shifts Metabolic Consumption from Amino Acids to Glucose in IPEC-J2 Cells and Intestinal Bacteria in Pigs.
An R; Tang Z; Li Y; Li T; Xu Q; Zhen J; Huang F; Yang J; Chen C; Wu Z; Li M; Sun J; Zhang X; Chen J; Wu L; Zhao S; Qingyan J; Zhu W; Yin Y; Sun Z
J Agric Food Chem; 2018 Apr; 66(15):3793-3800. PubMed ID: 29471628
[TBL] [Abstract][Full Text] [Related]
49. Characterization of Plasmodium Atg3-Atg8 Interaction Inhibitors Identifies Novel Alternative Mechanisms of Action in Toxoplasma gondii.
Varberg JM; LaFavers KA; Arrizabalaga G; Sullivan WJ
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158278
[TBL] [Abstract][Full Text] [Related]
50. Pravastatin and Simvastatin Pretreatment in Combination with Pyrimethamine and Sulfadiazine Reduces Infection Process of Toxoplasma gondii Tachyzoites (RH Strain) in HeLa Cells.
Sanfelice RADS; da Silva SS; Bosqui LR; Machado LF; Miranda-Sapla MM; Panagio LA; Navarro IT; Conchon-Costa I; Pavanelli WR; Almeida RS; Costa IN
Acta Parasitol; 2019 Sep; 64(3):612-616. PubMed ID: 31286354
[TBL] [Abstract][Full Text] [Related]
51. Dichloroacetate, the Pyruvate Dehydrogenase Complex and the Modulation of mESC Pluripotency.
Rodrigues AS; Correia M; Gomes A; Pereira SL; Perestrelo T; Sousa MI; Ramalho-Santos J
PLoS One; 2015; 10(7):e0131663. PubMed ID: 26147621
[TBL] [Abstract][Full Text] [Related]
52. Dichloroacetate treatment improves mitochondrial metabolism and reduces brain injury in neonatal mice.
Sun Y; Li T; Xie C; Zhang Y; Zhou K; Wang X; Blomgren K; Zhu C
Oncotarget; 2016 May; 7(22):31708-22. PubMed ID: 27153546
[TBL] [Abstract][Full Text] [Related]
53. Use of hyperpolarized [1-13C]pyruvate and [2-13C]pyruvate to probe the effects of the anticancer agent dichloroacetate on mitochondrial metabolism in vivo in the normal rat.
Hu S; Yoshihara HA; Bok R; Zhou J; Zhu M; Kurhanewicz J; Vigneron DB
Magn Reson Imaging; 2012 Dec; 30(10):1367-72. PubMed ID: 22819176
[TBL] [Abstract][Full Text] [Related]
54. Phosphorylation-mediated changes in pyruvate dehydrogenase activity influence pyruvate-supported calcium accumulation by brain mitochondria.
Browning M; Baudry M; Bennett WF; Lynch G
J Neurochem; 1981 Jun; 36(6):1932-40. PubMed ID: 7241145
[TBL] [Abstract][Full Text] [Related]
55. The regulation of pyruvate dehydrogenase activity in rat hippocampal slices: effect of dichloroacetate.
Baudry M; Kessler M; Smith EK; Lynch G
Neurosci Lett; 1982 Jul; 31(1):41-6. PubMed ID: 6289199
[TBL] [Abstract][Full Text] [Related]
56. Multi-modality imaging to assess metabolic response to dichloroacetate treatment in tumor models.
Neveu MA; De Preter G; Joudiou N; Bol A; Brender JR; Saito K; Kishimoto S; Grégoire V; Jordan BF; Krishna MC; Feron O; Gallez B
Oncotarget; 2016 Dec; 7(49):81741-81749. PubMed ID: 28082726
[TBL] [Abstract][Full Text] [Related]
57. Influence of dichloroacetate (DCA) on lactate production and oxygen consumption in neuroblastoma cells: is DCA a suitable drug for neuroblastoma therapy?
Niewisch MR; Kuçi Z; Wolburg H; Sautter M; Krampen L; Deubzer B; Handgretinger R; Bruchelt G
Cell Physiol Biochem; 2012; 29(3-4):373-80. PubMed ID: 22508045
[TBL] [Abstract][Full Text] [Related]
58. Unexpected Discovery of Dichloroacetate Derived Adenosine Triphosphate Competitors Targeting Pyruvate Dehydrogenase Kinase To Inhibit Cancer Proliferation.
Zhang SL; Hu X; Zhang W; Tam KY
J Med Chem; 2016 Apr; 59(7):3562-8. PubMed ID: 27006991
[TBL] [Abstract][Full Text] [Related]
59. Dichloroacetate, an inhibitor of pyruvate dehydrogenase kinases, inhibits platelet aggregation and arterial thrombosis.
Nayak MK; Dhanesha N; Doddapattar P; Rodriguez O; Sonkar VK; Dayal S; Chauhan AK
Blood Adv; 2018 Aug; 2(15):2029-2038. PubMed ID: 30108111
[TBL] [Abstract][Full Text] [Related]
60. Heterogeneous Expression and Subcellular Localization of Pyruvate Dehydrogenase Complex in Prostate Cancer.
Nunes-Xavier CE; Mingo J; Emaldi M; Flem-Karlsen K; Mælandsmo GM; Fodstad Ø; Llarena R; López JI; Pulido R
Front Oncol; 2022; 12():873516. PubMed ID: 35692804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
